Novel insights into the antiproliferative effects and synergism of quercetin and menadione in human leukemia Jurkat T cells

Leukemia Research

Volumn 38, Issue 7, 2014, Pages 836-849

  Baran, Irina ^a   Ionescu, Diana ^a   Filippi, Alexandru ^a   Mocanu, Maria Magdalena ^a   Iftime, Adrian ^a   Babes, Ramona ^a   Tofolean, Ioana Teodora ^a   Irimia, Ruxandra ^a   Goicea, Alexandru ^a   Popescu, Valentin ^a   Dimancea, Alexandru ^a   Neagu, Andrei ^a   Ganea, Constanta ^a  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Leukemia; Menadione; Mitochondrial depolarization hyperpolarization; Quercetin; Reactive oxygen species; Rotenone

Indexed keywords

MENADIONE; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; QUERCETIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CALCIUM TRANSPORT; CELL DEATH; CELL KILLING; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CLONOGENESIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFICACY; DRUG POTENTIATION; HUMAN; HUMAN CELL; HYPERPOLARIZATION; JURKAT CELL LINE; MITOCHONDRIAL HYPERPOLARIZATION; PRIORITY JOURNAL;

LEUKEMIA; MENADIONE; MITOCHONDRIAL DEPOLARIZATION/HYPERPOLARIZATION; QUERCETIN; REACTIVE OXYGEN SPECIES; ROTENONE;

CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; HUMANS; JURKAT CELLS; LEUKEMIA; MEMBRANE POTENTIALS; NAD; QUERCETIN; REACTIVE OXYGEN SPECIES; ROTENONE; VITAMIN K 3;

EID: 84902080873     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2014.04.010     Document Type: Article

References (71)

1. Murakami A., Ashida H., Terao J. Multitargeted cancer prevention by quercetin. Cancer Lett 2008, 269:315-325.
2. Chen G., Wang F., Trachootham D., Huang P. Preferential killing of cancer cells with mitochondrial dysfunction by natural compounds. Mitochondrion 2010, 10:614-625.
3. Kelly G.S. Quercetin. Altern Med Rev 2011, 16:172-194.
4. Russo M., Spagnuolo C., Tedesco I., Bilotto S., Russo G.L. The flavonoid quercetin in disease prevention and therapy: facts and fancies. Biochem Pharmacol 2012, 83:6-15.
5. Chen D., Daniel K.G., Chen M.S., Kuhn D.J., Landis-Piwowar K.R., Dou Q.P. Dietary flavonoids as proteasome inhibitors and apoptosis inducers in human leukemia cells. Biochem Pharmacol 2005, 69:1421-1432.
6. Rao Y.K., Geethangili M., Fang S.H., Tzeng Y.M. Antioxidant and cytotoxic activities of naturally occurring phenolic and related compounds: a comparative study. Food Chem Toxicol 2007, 45:1770-1776.
7. Jeong J.H., An J.Y., Kwon Y.T., Rhee J.G., Lee Y.J. Effects of low dose quercetin: cancer cell-specific inhibition of cell cycle progression. J Cell Biochem 2009, 106:73-82.
8. Yen G.C., Duh P.D., Tsai H.L., Huang S.L. Pro-oxidative properties of flavonoids in human lymphocytes. Biosci Biotechnol Biochem 2003, 67:1215-1222.
9. Cheng S., Gao N., Zhang Z., et al. Quercetin induces tumor-selective apoptosis through downregulation of Mcl-1 and activation of Bax. Clin Cancer Res 2010, 16:5679-5691.
10. Staedler D., Idrizi E., Kenzaoui B.H., Juillerat-Jeanneret L. Drug combinations with quercetin: doxorubicin plus quercetin in human breast cancer cells. Cancer Chemother Pharmacol 2011, 68:1161-1172.
11. Spagnuolo C., Russo M., Bilotto S., Tedesco I., Laratta B., Russo G.L. Dietary polyphenols in cancer prevention: the example of the flavonoid quercetin in leukemia. Ann N Y Acad Sci 2012, 1259:95-103.
12. Muggia F.M., Green M.D. New anthracycline antitumor antibiotics. Crit Rev Oncol Hematol 1991, 11:43-64.
13. Du G., Lin H., Wang M., et al. Quercetin greatly improved therapeutic index of doxorubicin against 4T1 breast cancer by its opposing effects on HIF-1α in tumor and normal cells. Cancer Chemother Pharmacol 2010, 65:277-287.
14. Wang G., Zhang J., Liu L., Sharma S., Dong Q. Quercetin potentiates doxorubicin mediated antitumor effects against liver cancer through p53/Bcl-xl. PLoS ONE 2012, 7:e51764.
15. Choi J.S., Piao Y.J., Kang K.W. Effects of quercetin on the bioavailability of doxorubicin in rats: role of CYP3A4 and P-gp inhibition by quercetin. Arch Pharm Res 2011, 34:607-613.
16. Chen C., Zhou J., Ji C. Quercetin: a potential drug to reverse multidrug resistance. Life Sci 2010, 87:333-338.
17. Yuan Z.P., Chen L.J., Fan L.Y., et al. Liposomal quercetin efficiently suppresses growth of solid tumors in murine models. Clin Cancer Res 2006, 12:3193-3199.
18. Ferry D.R., Smith A., Malkhandi J., et al. Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin Cancer Res 1996, 2:659-668.
19. He B., Wang X., Shi H.S., et al. Quercetin liposome sensitizes colon carcinoma to thermotherapy and thermochemotherapy in mice models. Integr Cancer Ther 2013, 12:264-270.
20. Wong M.Y., Chiu G.N.C. Liposome formulation of co-encapsulated vincristine and quercetin enhanced antitumor activity in a trastuzumab-insensitive breast tumor xenograft model. Nanomedicine 2011, 7:834-840.
21. Baran I., Ganea C., Scordino A., et al. Effects of menadione, hydrogen peroxide and quercetin on apoptosis and delayed luminescence of human leukemia Jurkat T-cells. Cell Biochem Biophys 2010, 58:169-179.
22. Baran I., Ganea C., Privitera S., et al. Detailed analysis of apoptosis and delayed luminescence of human leukemia Jurkat T cells after proton-irradiation and treatments with oxidant agents and flavonoids. Oxid Med Cell Longev 2012, 2012:498914.
23. Baran I., Katona E., Ganea C. Quercetin as a fluorescent probe for the ryanodine receptor activity in Jurkat cells. Pflug Arch Eur J Phy 2013, 465:1101-1119.
24. 2+ release flux in intact Jurkat cells. Arch Biochem Biophys 2013, 540:145-159.
25. Baran I., Ganea C., Ursu I., et al. Fluorescence properties of quercetin in human leukemia Jurkat T-cells. Rom J Phys 2011, 56:388-398.
26. 3 using as an enhancer of anticancer agents. Biol Pharm Bull 2008, 31:1270-1273.
27. Laux I., Nel A. Evidence that oxidative stress-induced apoptosis by menadione involves Fas-dependent and Fas-independent pathways. Clin Immunol 2001, 101:335-344.
28. 3 and vitamin C alone or in combination induced apoptosis in leukemia cells by a similar oxidative stress signalling mechanism. Cancer Cell Int 2011, 11:19.
29. Akman S.A., Dietrich M., Chlebowski R.T., Limberg P., Block J.B. Modulation of cytotoxicity of menadione sodium bisulfite versus leukemia L1210 by the acid-soluble thiol pool. Cancer Res 1985, 45:5257-5262.
30. Margolin K.A., Akman S.A., Leong L.A., et al. Phase I study of mitomycin C and menadione in advanced solid tumors. Cancer Chemother Pharmacol 1995, 36:293-298.
31. 3) in advanced malignancy. Invest New Drugs 2005, 23:235-239.
32. Tetef M., Margolin K., Ahn C., et al. Mitomycin C and menadione for the treatment of lung cancer: a phase II trial. Invest New Drugs 1995, 13:157-162.
33. Tetef M., Margolin K., Ahn C., et al. Mitomycin C and menadione for the treatment of advanced gastrointestinal cancers: a phase II trial. J Cancer Res Clin Oncol 1995, 121:103-106.
34. Lamson D.W., Plaza S.M. The anticancer effects of vitamin K. Altern Med Rev 2003, 8:303-318.
35. Mamede A.C., Tavares S.D., Abrantes A.M., Trindade J., Maia J.M., Botelho M.F. The role of vitamins in cancer: a review. Nutr Cancer 2011, 63:479-494.
36. 3) on drug cytotoxicity in sensitive and MDR P388 leukemia cells. Cancer Lett 1992, 61:147-156.
37. Tareen B., Summers J.L., Jamison J.M., et al. A 12 week, open label, phase I/IIa study using apatone for the treatment of prostate cancer patients who have failed standard therapy. Int J Med Sci 2008, 5:62-67.
38. Vlachodimitropoulou E., Sharp P.A., Naftalin R.J. Quercetin-iron chelates are transported via glucose transporters. Free Radical Biol Med 2011, 50:934-944.
39. Fiorani M., Guidarelli A., Blasa M., et al. Mitochondria accumulate large amounts of quercetin: prevention of mitochondrial damage and release upon oxidation of the extramitochondrial fraction of the flavonoid. J Nutr Biochem 2010, 21:397-404.
40. Baran I., Ionescu D., Privitera S., et al. Mitochondrial respiratory Complex I probed by delayed luminescence spectroscopy. J Biomed Optics 2013, 18:127006.
41. De Marchi U., Biasutto L., Garbisa S., Toninello A., Zoratti M. Quercetin can act either as an inhibitor or an inducer of the mitochondrial permeability transition pore: a demonstration of the ambivalent redox character of polyphenols. Biochim Biophys Acta 2009, 1787:1425-1432.
42. Criddle D.N., Gerasimenko J.V., Baumgartner H.K., et al. Calcium signalling and pancreatic cell death: apoptosis or necrosis?. Cell Death Differ 2007, 14:1285-1294.
43. 2+ requirement for mitochondrial permeability transition pore (mPTP) opening. J Biol Chem 2009, 284:20796-20803.
44. Biasutto L., Dong L.F., Zoratti M., Neuzil J. Mitochondrially targeted anti-cancer agents. Mitochondrion 2010, 10:670-681.
45. Johnson M.K., Loo G. Effects of epigallocatechin gallate and quercetin on oxidative damage to cellular DNA. Mutat Res 2000, 459:211-218.
46. Ferraresi R., Troiano L., Roat E., et al. Essential requirement of reduced glutathione (GSH) for the anti-oxidant effect of the flavonoid quercetin. Free Radical Res 2005, 39:1249-1258.
47. Floreani M., Carpenedo F. One- and two-electron reduction of menadione in guinea-pig and rat cardiac tissue. Gen Pharmacol 1992, 23:757-762.
48. Xu X., Arriaga E.A. Qualitative determination of superoxide release at both sides of the mitochondrial inner membrane by capillary electrophoretic analysis of the oxidation products of triphenylphosphonium hydroethidine. Free Rad Biol Med 2009, 46:905-913.
49. Li N., Ragheb K., Lawler G., et al. Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J Biol Chem 2003, 278:8516-8525.
50. Chen Q., Gong B., Mahmoud-Ahmed A.S., et al. Apo2L/TRAIL and Bcl-2-related proteins regulate type I interferon-induced apoptosis in multiple myeloma. Blood 2001, 98:2183-2192.
51. Mayevsky A., Rogatsky G.G. Mitochondrial function in vivo evaluated by NADH fluorescence: from animal models to human studies. Am J Physiol Cell Physiol 2007, 292:C615-C640.
52. Gaspers L.D., Thomas A.P. Calcium-dependent activation of mitochondrial metabolism in mammalian cells. Methods 2008, 46:224-232.
53. 2+ during increased work in intact rat heart trabeculae. Biophys J 2002, 83:587-604.
54. 2+] levels during short-term 17°C ischemia in intact hearts. Cardiovasc Res 2004, 61:580-590.
55. Robinson K.M., Janes M.S., Pehar M., et al. Selective fluorescent imaging of superoxide in vivo using ethidium-based probes. Proc Natl Acad Sci USA 2006, 103:15038-15043.
56. Chou T.C. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res 2010, 70:440-446.
57. Gutman M., Singer T.P., Casida J.E. Role of multiple binding sites in the inhibition of NADH oxidase by piericidin and rotenone. Biochem Biophys Res Commun 1969, 37:615-622.
58. Carrasco-Pozo C., Mizgier M.L., Speisky H., Gotteland M. Differential protective effects of quercetin, resveratrol, rutin and epigallocatechin gallate against mitochondrial dysfunction induced by indomethacin in Caco-2 cells. Chem Biol Interaction 2012, 195:199-205.
59. Lagoa R., Graziani I., Lopez-Sanchez C., Garcia-Martinez V., Gutierrez-Merino C. Complex I and cytochrome c are molecular targets of flavonoids that inhibit hydrogen peroxide production by mitochondria. Biochim Biophys Acta 2011, 1807:1562-1572.
60. Sandoval-Acuña C., Lopez-Alarcón C., Aliaga M.E., Speisky H. Inhibition of mitochondrial complex I by various non-steroidal anti-inflammatory drugs and its protection by quercetin via a coenzyme Q-like action. Chem Biol Interaction 2012, 199:18-28.
61. Brière J.J., Schlemmer D., Chretien D., Rustin P. Quinone analogues regulate mitochondrial substrate competitive oxidation. Biochem Biophys Res Commun 2004, 316:1138-1142.
62. O'Brien P.J. Molecular mechanisms of quinone cytotoxicity. Chem Biol Interaction 1991, 80:1-41.
63. 0) mutants. Biophys J 2003, 84:1291-1298.
64. Isenberg J.S., Klaunig J.E. Role of the mitochondrial membrane permeability transition (MPT) in rotenone-induced apoptosis in liver cells. Toxicol Sci 2000, 53:340-351.
65. Gao X., Dinkova-Kostova A.T., Talalay P. Powerful and prolonged protection of human retinal pigment epithelial cells, keratinocytes, and mouse leukemia cells against oxidative damage: the indirect antioxidant effects of sulforaphane. Proc Natl Acad Sci USA 2001, 98:15221-15226.
66. 2 - implications for their role in disease, especially cancer. J Bioenerg Biomembr 2011, 43:541-564.
67. Suzuki H., King T.E. Evidence of an ubisemiquinone radical(s) from the NADH-ubiquinone reductase of the mitochondrial respiratory chain. J Biol Chem 1983, 258:352-358.
68. Grivennikova V.G., Maklashina E.O., Gavrikova E.V., Vinogradov A.D. Interaction of the mitochondrial NADH-ubiquinone reductase with rotenone as related to the enzyme active/inactive transition. Biochim Biophys Acta 1997, 1319:223-232.
69. Covian R., Gutierrez-Cirlos E.B., Trumpower B.L. Anti-cooperative oxidation of ubiquinol by the yeast cytochrome bc1 complex. J Biol Chem 2004, 279:15040-15049.
70. Berden J.A., Slater E.C. The allosteric binding of antimycin to cytochrome b in the mitochondrial membrane. Biochim Biophys Acta 1972, 256:199-215.
71. Lenaz G., Genova M.L. Kinetics of integrated electron transfer in the mitochondrial respiratory chain: random collisions vs. solid state electron channeling. Am J Physiol Cell Physiol 2007, 292:C1221-C1239.